Bed Bath & Beyond Inc (BBBY) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available. The company's financial performance is weak, with declining revenue, net income, and EPS. While there are some positive technical indicators and a chance of short-term price increases, the lack of significant positive catalysts, weak financials, and neutral sentiment from hedge funds and insiders suggest that holding off on investing in this stock is the better choice.
The MACD histogram is positive and expanding, suggesting bullish momentum. The RSI is in the neutral zone at 69.318, and moving averages are converging, indicating no clear trend. Key resistance levels are at 5.255 and 5.525, while support levels are at 4.38 and 4.11. The stock has a 70% chance of increasing by 10.95% in the next day and 47.53% in the next month.

The MACD is expanding positively, and there is a 70% chance of short-term price increases. Gross margin increased by 7.05% YoY in the latest quarter.
Revenue, net income, and EPS have significantly declined YoY. Analysts have lowered price targets, and there is no recent news or significant insider/hedge fund activity. The market sentiment is neutral, and there are no recent congress trading data or influential figure transactions.
In Q4 2025, revenue dropped by 9.80% YoY to $273.43M, net income dropped by 74.31% YoY to -$20.88M, and EPS dropped by 81.93% YoY to -0.3. However, gross margin increased by 7.05% YoY to 24.6%.
Analysts have lowered price targets recently. Piper Sandler reduced the target to $8 from $10, maintaining a Neutral rating, citing uncertainty in the company's framework. Wedbush lowered the target to $7 from $13 but maintained an Outperform rating, noting some positive trends in website data and incremental optimism for the core business.